Testing effectiveness (Phase 2)Study completedNCT01986920
What this trial is testing
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
Who this might be right for
Seborrheic Keratosis (SK)
Aclaris Therapeutics, Inc. 35